Cite
HARVARD Citation
Saad, E. et al. (n.d.). Evaluation of disease-free survival (DFS) as a surrogate for overall survival (OS) in the adjuvant therapy of HER2-positive early breast cancer (EBC) calls for individual-patient data (IPD). Breast. pp. S26-. [Online].